Related Articles
Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer
Drug resistance mechanisms and progress in the treatment of EGFR‑mutated lung adenocarcinoma (Review)
A sensitive and practical method to detect the T790M mutation in the epidermal growth factor receptor
Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report